Biologic and social factors predict incident kidney disease in type 1 diabetes: Results from the T1D exchange clinic network

被引:2
|
作者
McGill, Janet B. [1 ]
Wu, Mengdi [2 ]
Pop-Busui, Rodica [3 ]
Mizokami-Stout, Kara [3 ]
Tamborlane, William, V [4 ]
Aleppo, Grazia [5 ]
Gubitosi-Klug, Rose A. [6 ]
Haller, Michael J. [7 ]
Willi, Steven M. [8 ,11 ]
Foster, Nicole C. [2 ]
Zimmerman, Chelsea [7 ]
Libman, Ingrid [9 ]
Polsky, Sarit [10 ]
Rickels, Michael R. [11 ]
机构
[1] Washington Univ, Sch Med, St Louis, MO USA
[2] Jaeb Ctr Hlth Res, 15310 Amberly Dr,Suite 350, Tampa, FL 33647 USA
[3] Univ Michigan, Dept Internal Med, Div Metab Endocrinol & Diabet, Ann Arbor, MI 48109 USA
[4] Yale Univ, Sch Med, New Haven, CT USA
[5] Northwestern Univ, Chicago, IL 60611 USA
[6] Univ Hosp Cleveland, Cleveland, OH 44106 USA
[7] Univ Florida, Gainesville, FL USA
[8] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA
[9] UPMC, Childrens Hosp Pittsburgh, Pittsburgh, PA USA
[10] Barbara Davis Ctr Diabet, Aurora, CO USA
[11] Univ Penn, Rodebaugh Diabet Ctr, Perelman Sch Med, Philadelphia, PA 19104 USA
关键词
Type; 1; diabetes; Diabetic kidney disease; T1D exchange; Diabetes management; Glycemic management; CONVERTING ENZYME-INHIBITION; GLOMERULAR-FILTRATION-RATE; INSULIN INJECTION THERAPY; GLYCEMIC CONTROL; PITTSBURGH EPIDEMIOLOGY; SOCIOECONOMIC-STATUS; COMPLICATIONS TRIAL; BLOOD-PRESSURE; FOLLOW-UP; ALBUMINURIA;
D O I
10.1016/j.jdiacomp.2019.06.005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims: Diabetic kidney disease (DKD) is a major complication of type 1 diabetes (T1D). To better understand the development of DKD in modern clinical practice, we evaluated risk factors in participants from the T1D Exchange Registry who completed 5-years of longitudinal follow-up. Methods: Participants had T1D duration >= 1 year, age >= 10 years, eGFR >= 60 ml/min and no albuminuria at enrollment, and at least two serum creatinine and urine albumin measurements recorded during follow-up. Adverse kidney outcomes were defined as eGFR << 60 ml/min and/or albuminuria (ALB) defined by as two consecutive albumin/creatinine ratios or two out of the past three measurements >> 30 mu g/mg at any follow-up data collection. Associations of baseline characteristics with adverse kidney outcomes were assessed. Results: Among 3940 participants (mean age 41 +/- 15 yrs, T1D duration 21 +/- 13 yrs), 653 (16.6%) experienced an adverse kidney outcome: 268 (6.8%) experienced incident ALB only, 322 (8.2%) had eGFR decline to << 60 ml/min without ALB, and 63 (1.6%) experienced eGFR << 60 ml/min with ALB. In a multivariable analysis, higher HbA1c, higher SBP, lower DBP, older age and lower education level were associated with the development of adverse kidney outcomes (all p values <= 0.03). Conclusions: Improving modifiable risk factors, including glucose and blood pressure control, remain important to reduce the risk of DKD in T1D. (C) 2019 Elsevier Inc. All rights reserved.
引用
收藏
页数:4
相关论文
共 50 条
  • [31] Similar Intrapatient Blood Glucose Variability with LY2963016 and LantusA® Insulin Glargine in Patients with Type 1 (T1D) or Type 2 Diabetes, Including a Japanese T1D Subpopulation
    Nishiyama, Hiroshi
    Shingaki, Tomotaka
    Suzuki, Yumi
    Ilag, Liza L.
    DIABETES THERAPY, 2018, 9 (04) : 1469 - 1476
  • [32] Differences in the Management of Type 1 Diabetes Among Adults Under Excellent Control Compared With Those Under Poor Control in the T1D Exchange Clinic Registry
    Simmons, Jill H.
    Chen, Vincent
    Miller, Kellee M.
    McGill, Janet B.
    Bergenstal, Richard M.
    Goland, Robin S.
    Harlan, David M.
    Largay, Joseph F.
    Massaro, Elaine M.
    Beck, Roy W.
    DIABETES CARE, 2013, 36 (11) : 3573 - 3577
  • [33] Disparities in Continuous Glucose Monitoring Use Among Women of Reproductive Age with Type 1 Diabetes in the T1D Exchange
    Venkatesh, Kartik K.
    Powe, Camille E.
    Buschur, Elizabeth
    Wu, Jiqiang
    Landon, Mark B.
    Gabbe, Steven
    Gandhi, Kajal
    Grobman, William A.
    Fareed, Naleef
    DIABETES TECHNOLOGY & THERAPEUTICS, 2023, 25 (03) : 201 - 205
  • [34] Continuous glucose monitoring and glycemic control among youth with type 1 diabetes: International comparison from the T1D Exchange and DPV Initiative
    DeSalvo, Daniel J.
    Miller, Kellee M.
    Hermann, Julia M.
    Maahs, David M.
    Hofer, Sabine E.
    Clements, Mark A.
    Lilienthal, Eggert
    Sherr, Jennifer L.
    Tauschmann, Martin
    Holl, Reinhard W.
    PEDIATRIC DIABETES, 2018, 19 (07) : 1271 - 1275
  • [35] The beta cell-immune cell interface in type 1 diabetes (T1D)
    James, Eddie A.
    Joglekar, Alok V.
    Linnemann, Amelia K.
    Russ, Holger A.
    Kent, Sally C.
    MOLECULAR METABOLISM, 2023, 78
  • [36] Immunotherapy of type 1 diabetes - How to rationally prioritize combination therapies in T1D
    Boettler, Tobias
    von Herrath, Matthias
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2010, 10 (12) : 1491 - 1495
  • [37] Environmental exposures and blood pressure in adolescents and adults in the T1D exchange clinic registry
    Griggs, Stephanie
    Pignatiello, Grant
    Motairek, Issam
    Rieke, Jorden
    Howard, Quiana
    Crawford, Sybil L.
    Rajagopalan, Sanjay
    Al-Kindi, Sadeer
    Hickman Jr, Ronald L.
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2023, 37 (10)
  • [38] Human leukocyte antigen class I B and C loci contribute to type 1 diabetes (T1D) susceptibility and age T1D onset
    Valdes, AM
    Erlich, HA
    Noble, JA
    HUMAN IMMUNOLOGY, 2005, 66 (03) : 301 - 313
  • [39] Research recommendations from the 2024 Breakthrough T1D, Diabetes UK and Kidney Research UK, diabetes and kidney disease expert workshop
    Markham-Lee, Zoe
    Bhagat-Jones, Swati
    Carlton, Jill
    Frankel, Andrew
    Fraser, Simon
    Habte-Asres, Hellena H.
    Hill, Claire
    Kanumilli, Naresh
    Karalliedde, Janaka
    Maskell, Annelie
    Mcknight, Amy Jayne
    Morris, Anna
    Nitsch, Dorothea
    Otake John, Nia
    Parks, Steven
    Robinson, Sarah Jane
    Rosenthal, Miranda
    Rutter, Martin K.
    Schmutz, Caroline
    Scullion, Shawna
    Smith, Rachel
    Tarm, Linda
    Wheeler, David C.
    Newman, Daniel
    Mistry, Sanjay
    Mccafferty, Kieran
    Hills, Claire E.
    DIABETIC MEDICINE, 2025,
  • [40] State of Type 1 Diabetes Care in the United States in 2016-2018 from T1D Exchange Registry Data
    Rodbard, David
    DIABETES TECHNOLOGY & THERAPEUTICS, 2019, 21 (02) : 62 - 65